# Aibo Qingshi Venture Capital Fund

> Aibo Qingshi Venture Capital Fund is a VC fund backing Health Care and Medical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Dec 2024
- Lead investor: 20%
- Last updated: Aug 2026

Aibo Qingshi Venture Capital Fund is a VC fund focused on Health Care and Medical. Aibo Qingshi Fund is a venture capital fund co-operated by Aibo Medical (688050.SH) and Qingshi Asset Management Group.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Medical | 2 | 40% |
| Manufacturing | 2 | 40% |
| Medical Device | 2 | 40% |
| Dental | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 40% |
| Seed | 1 | 20% |
| Series A | 1 | 20% |
| Series C | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zhitong Technology | Zhitong Medical is a provider of computational imaging technology that focuses on the development of surgical vision. | $13.7M | Series A | Dec 16, 2024 |  |
| Sieran Medical | Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology. | $14.1M | Seed | Sep 05, 2024 |  |
| X-Imaging | X-Imaging provides full-process automation and intelligent, comprehensive solutions. They are molecules to cells for biochemistry, medical medicine, and safety inspection and testing. The product range covers food safety, drug safety, life science fields, and intelligent robot workstation systems. | $13.9M | Series B | Dec 11, 2023 |  |
| CytoNiche | CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated andintelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products. | $47.5M | Series B | Mar 03, 2022 |  |
| Zhengli Technology | Zhengli Technology is a company that focuses on the research and development, production and sales of first-class invisible orthodontic products, dental restoration products and dental professional software systems. Spirit, to provide all-round one-stop solutions for dental professionals in China and the world. | $15.7M | Series C | Dec 29, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 2 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 2 deals together
- [Aier Eye Hospital Group](https://shizune.co/investors/profile/aier-eye-hospital-group) — VC Fund, 1 deal together
- [Hongtai Capital Holdings](https://shizune.co/investors/profile/aplus-capital) — VC Fund, 1 deal together
- [Apricot Capital](https://shizune.co/investors/profile/apricot-capital-ceb8) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Aibo Qingshi Venture Capital Fund invest in?

Aibo Qingshi Venture Capital Fund invests primarily in Health Care, Medical and Manufacturing startups, most often at Series B and Seed stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Aibo Qingshi Venture Capital Fund last invest?

The most recent investment recorded for Aibo Qingshi Venture Capital Fund closed in Dec 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co